amarin

An Analytical Analysis of Vascepa® (Icosapent Ethyl) Fatty Acid Composition with Comparison to Advertised Ingredient Claims and Fatty Acid Profiles of Lovaza® and Nature’s Bounty® Fish Oil. Introduction: FDA-approved Vascepa is prescribed to patients with hypertriglyceridemia to reduce high...

I am currently interviewing with Amarin and am deciding if it would be a good fit for me. What do you like about working here? What is the culture like? What is the car reimbursement? Are bonuses paid out monthly or quarterly?

I expect that Amarin will bounce back from the recent sell-off. Most of the doctors who participated in the AHA event has said that they will prescribe Vascepa and next year the biggies like Pfizer might considering acquiring Amarin...

There are rumors that Pfizer would take over Amarin, which skyrocketed today in the stock market as the cardiovascular study met primary and secondary endpoints using Vascepa drug. But Amarin has said that it's just a speculation...

Looks like an all cash offer happening soon. Anyone in home office can confirm this in any way. see the link http://www.dailymail.co.uk/money/markets/article-2221989/MARKET-REPORT-Amarin-cure-Astra.html Something new to sell

http://seekingalpha.com/article/800421-amarin-buyout-rumors-gaining-traction?source=yahoo Amarin Buyout Rumors Gaining Traction? August 11, 2012 *|*7 comments *|* about: AMRN, includes: GSK, MRK It is well known that Amarin Corporation PLC (AMRN) management prefers a buyout as the path to...